Dr Henry Sidney Pohl, MD | |
47 New Scotland Ave, Albany, NY 12208-3412 | |
(518) 262-5276 | |
(518) 262-6470 |
Full Name | Dr Henry Sidney Pohl |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 47 New Scotland Ave, Albany, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982699054 | NPI | - | NPPES |
00461270 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 116337-1 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Henry Sidney Pohl, MD 47 New Scotland Ave, Albany, NY 12208-3412 Ph: (518) 262-5276 | Dr Henry Sidney Pohl, MD 47 New Scotland Ave, Albany, NY 12208-3412 Ph: (518) 262-5276 |
News Archive
Pfizer Inc. and Ergonex Pharma GmbH announced today that they have entered into an agreement under which Pfizer will acquire terguride, which is in development as a potential treatment for Pulmonary Arterial Hypertension.
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
With a new grant from the U.S. Army, a team of scientists will seek to enhance artificial intelligence by integrating brain cells called astrocytes.
A Mayo Clinic study demonstrates that only those multiple sclerosis (MS) patients with evidence for antibody deposition or complement activation - immune cells that can cause tissue destruction - in their lesions are likely to respond to plasma exchange, a treatment for acute MS attacks.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
› Verified 2 days ago
Arunima Rajbhandary, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1550 | |
Dr. Rahul Ravilla, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 43 New Scotland Ave Ste 7, Albany, NY 12208 Phone: 518-262-6696 Fax: 518-262-2624 | |
Emmanuelle Cordero Torres, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave Dept Of Nephrology, Albany Medical Center, Albany, NY 12208 Phone: 518-262-5377 | |
Nancy Shrestha, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 5 Palisades Dr Ste 200, Albany, NY 12205 Phone: 518-471-3636 Fax: 518-471-3668 | |
Stephen Hillinger, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 400 Patroon Creek Blvd, Suite 1, Albany, NY 12206 Phone: 518-489-0044 Fax: 518-489-3591 | |
Louis H Gold, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5 Palisades Dr, Ste100, Albany, NY 12205 Phone: 518-438-4496 | |
Sean Joseph Sheehan, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1375 Washington Ave, Suite 101, Albany, NY 12206 Phone: 518-438-4483 Fax: 518-482-4201 |